We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

195 hedge funds and large institutions have $841M invested in Avid Bioservices, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 47 increasing their positions, 51 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,180% more call options, than puts

Call options by funds: $3.21M | Put options by funds: $141K

500% more funds holding in top 10

Funds holding in top 10: 16 (+5)

65% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 40

14% more funds holding

Funds holding: 171195 (+24)

9% more capital invested

Capital invested by funds: $772M → $841M (+$69M)

8% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 51

Holders
195
Holders Change
+24
Holders Change %
+14.04%
% of All Funds
2.57%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.08%
New
66
Increased
47
Reduced
51
Closed
40
Calls
$3.21M
Puts
$141K
Net Calls
+$3.07M
Net Calls Change
+$3.29M

CDMO Hedge Fund Activity: Q4 2024 in Review

195 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2024, worth a combined $841M — up 8.9% from $772M a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new CDMO positions and 40 closed out — a net gain of 26 holders — while 47 added to existing stakes and 51 trimmed.

The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $42.6M. The largest seller was Millennium Management, cutting an estimated $43.7M.

  • 195 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2024, up from 171 in Q3 2024.
  • Funds reported $841M of Avid Bioservices, Inc. Common Stock stock for Q4 2024, up 8.9% quarter-over-quarter.
  • 66 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2024 and 40 closed out, a net change of +26 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2024 was Glazer Capital LLC, an estimated $42.6M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q4 2024 was Millennium Management, an estimated $43.7M sold.

Based on aggregated 13F filings for Q4 2024.